1842 жылдан бері UCL Фармацевтика мектебінің тарихы мен құрылымы

The School was founded in 1842 by the Pharmaceutical Society of Great Britain. The School began offering University of London degrees in 1925 and joined the university as a specialist school in 1949. To its alumni and colleagues in the profession it is known as "the Square", which refers to the fact that it was originally located in Bloomsbury Square and now in Brunswick Square. It was decided on 13 May 2011, after a consultation and development process, that the School would merge with University College London (UCL). The merger was completed on 1 January 2012, and the School was renamed the UCL School of Pharmacy.

The School is organised into four academic departments, each with one or more associated specialist research centres.

The Department of Pharmaceutical and Biological Chemistry is the largest of the School's departments. Its research is focused on cancer, natural products and phytomedicines, molecular neurosciences and biopharmaceutical analysis. The department's staff help teach the undergraduate MPharm degree in the areas of drug discovery, medicinal chemistry, pharmaceutical chemistry and pharmacognosy/medicinal plants, and an MSc in Pharmacognosy is offered.

The Wellcome Department of Pharmacology is one of the oldest departments of pharmacology in the UK. The department has played a major role in the development of Pharmacology in the UK and many pharmacologists who trained here are to be found in academies and in industries all over the world. The department's research focuses on the nervous system, and a wide range of approaches are used to study normal brain function and the causes of many neurological and psychiatric diseases.

The Department of Pharmaceutics is home to a wide range of research activities, such as in Materials Science and Processing and Clinical Pharmaceutical Science. The department's research in Materials Science and Processing is centred on the fundamental properties of materials and their adaptation to optimise processing and enhance drug delivery. It operates a number of joint ventures, including the Centre for Paediatric Pharmacy Research, a joint venture with Great Ormond Street Hospital and the Institute of Child Health, and in the Clinical Pharmaceutics with University College Hospitals and Camden and Islington's NHS Trust. The Microbiology Research Group is also well established, with work focusing mainly in overcoming antibiotic resistance and obtaining new actives from natural sources. The Group has been particularly successful in investigating new approaches to the treatment of the 'superbug' MRSA.

The Department of Practice and Policy focuses upon making the use of medicines safer and more effective through teaching, service and research. The department has collaborations with organisations including Imperial College London, the London School of Economics, the Institute of Education and the London School of Hygiene and Tropical Medicine, as well as several major London hospitals including Guy's and St Thomas's, University College Hospital, Hammersmith, Barts and the London, and Great Ormond Street. The department's staff are involved in curricular development and teaching across all four years of the MPharm course. Its student body includes hospital pharmacists studying for a range of Certificate, Diploma and MSc qualifications.

The School offers a number of master's degree programmes, including Drug Discovery, Drug Delivery, Pharmacognosy and Pharmacy Practice, and PhD research degrees. The only undergraduate degree which it currently offers is the four year MPharm, Master of Pharmacy. The School offered BSc degrees in Toxicology and Pharmacology until 2001.

In 2010/11 the School had a total research income of £8.13 million. In the 2008 Research Assessment Exercise, 90 per cent of the research activity at the School was deemed "internationally significant" and 25 per cent "world leading".